Baidu
map

就疾病贴吧出卖事件,为百度代拟辩护词

2016-01-13 蔡晓峰 MedSci原创

近日,百度贴吧上了新闻头条:有网友称血友病贴吧被出卖,原吧务人员被无故撤换,换上的新吧主,却曾经被媒体揭露过“非法行医”、“违规乱收患者”。此后又有网友发帖举报,称约有40%的热门疾病贴吧被出卖,甲亢吧、不孕不育吧、股骨头坏死吧、癫痫吧、高血压吧……,这些疾病贴吧的实际控制者都是资质可疑的机构或个人。要说百度到底是大公司,公关力量强大,迅速作出反应,贴吧事件11日上头条,12日百度公司就宣称,“百

近日,百度贴吧上了新闻头条:有网友称血友病贴吧被出卖,原吧务人员被无故撤换,换上的新吧主,却曾经被媒体揭露过“非法行医”、“违规乱收患者”。此后又有网友发帖举报,称约有40%的热门疾病贴吧被出卖,甲亢吧、不孕不育吧、股骨头坏死吧、癫痫吧、高血压吧……,这些疾病贴吧的实际控制者都是资质可疑的机构或个人。

要说百度到底是大公司,公关力量强大,迅速作出反应,贴吧事件11日上头条,12日百度公司就宣称,“百度贴吧所有病种类吧全面停止商业合作,只对权威公益组织开放”。不过百度并没有对自己出卖疾病贴吧的行径进行辩解,而是选择打落牙齿肚里咽。相比之下,百度的小伙伴莆田系前年被新东方老大俞敏洪炮轰时,还曾经写了一篇义正词严的辩护雄文,最近的快播庭审中,快播CEO王欣也以“技术本身并不可耻”来为自己辩护,而百度就此一声都不辩解,似乎太过委屈。因此,我路见不平拔刀相助,帮百度代拟一篇辩护文。

首先,借用王欣老师的话,“技术本身并不可耻”。我们百度是一家技术型的公司,坏人可以用我们的技术,好人也可以用我们的技术。虚假医疗广告的发布者即使不来找我们百度,也可以去贴在电线杆上啊,我们百度就好比电线杆。你看了电线杆上的牛皮癣广告上了当,会去把电线杆砍了吗?当然了,我们百度跟电线杆还是不同的,电线杆不收钱,我们百度是一家高大上的技术型公司,我们要收客户钱的,收了钱就要服务好客户,不管他是非法行医的,还是做其他什么勾当的,都是我们百度的上帝。什么,你说技术本身并不可耻,但用技术干坏事的人可耻?呃,这个我承认你说得对,不过反正很多骂我们无耻的文章后来都消失了。

有人在文章里骂我们:“百度完全不在意自己的搜索结果,如果可以把所有的内容都换成广告却不影响访问量的话,我想百度绝对会去这么做。”我觉得这种说法特别不靠谱。我们百度又不是只提供虚假信息,我们也有真信息的好不好?网民又不傻,如果没有真信息,百度哪里能做到今天这么大?这就好比《鹿鼎记》里面韦小宝撒谎,十句里面有九句是真的,但坑人就坑在那句假的上面。要是一句真的都没有,谁会信你?当然,我们提供的信息,真假比较难分辨倒是真的,以前不是还有网友搜到百度投诉中心电话都是假的吗,我们总不会为了收钱,把假冒我们百度的信息也给推广了吧。

再说了,做虚假医疗广告的又不是只有我们百度一家。今天骂我们的媒体有几个敢拍着胸脯说我们没有做过虚假医疗广告?和尚摸得,我摸不得?说我们的疾病贴吧卖掉之后,什么偏方泛滥之类的,可是我看有些所谓的正规媒体也在宣传这种不靠谱的偏方嘛,甚至还有某某科技出版社出版《××偏方》之类的书籍呢,有几个受到处罚了?国家卫生计生委倒是出过一个健康科普信息的生成与传播指南,指出科普信息要有五个注明、一个明确(注明来源、作者、时间、受众、依据,明确目的),但有几家人家认认真真照着这个指南做的?既然网上垃圾信息多,我们百度作为搜索引擎,给网民提供的信息,自然也只能是垃圾多了。退一万步说,就算我们金盆洗手,不搞竞价广告了,老老实实做搜索,那些不靠谱的机构和个人,把花在竞价广告上的钱,去请人做SEO,不是照样能排到搜索结果的前列吗?

你们不是都爱拿我们曾经的竞争对手、现在已经访问不了的那家搜索引擎说事吗?你以为真是那家公司道德比我们高尚很多吗?我看不见得。你不看看人家那个国家法律多严格,执法多不留情。前不久,有个叫金·卡戴珊的女明星,用自己的社交网站帐号推介了一个叫做Diclegis的孕期止吐药。跟我们那些广告比起来,这都不是个事儿。Diclegis是美国FDA批准的合法药物,美国法律本来就允许处方药做广告,卡戴珊也不过是在社交网站上介绍自己孕吐的经历,结果就被FDA找上了。FDA认为卡戴珊的帖子淡化了这个药品的不良反应,因此对卡戴珊和生产那个药品的厂家都发出了警告,结果卡戴珊马上乖乖地把违规的帖子给删了。我们百度卖了这么多疾病贴吧给不靠谱的机构和个人,做了这么多虚假医疗广告,有公开收到过类似的警告信或者受到处罚吗?

所以,其实这次我们是迫于舆论的压力,不得不收敛了起来。不过请你们放心,我认为改邪归正不是很难的事情,以前每当风声紧的时候,我们都会这么改邪归正一下的。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1591872, encodeId=80d915918e25e, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Fri Jan 15 09:06:00 CST 2016, time=2016-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57162, encodeId=d2205e16212, content=怎么说呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Thu Jan 14 07:16:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57102, encodeId=80ad5e1021f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Wed Jan 13 23:32:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57029, encodeId=deca5e0298e, content=度爷, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Jan 13 18:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57024, encodeId=3f6c5e02417, content=对就是对,错就是错, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/e3b78fdf1c4d3e2e9ec6e03f643df0e2/6ca494c7b27a25fdde0721c5dac778d7.jpg, createdBy=2e441664544, createdName=鲜花飞鸟, createdTime=Wed Jan 13 18:27:00 CST 2016, time=2016-01-13, status=1, ipAttribution=)]
    2016-01-15 tcm105hq
  2. [GetPortalCommentsPageByObjectIdResponse(id=1591872, encodeId=80d915918e25e, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Fri Jan 15 09:06:00 CST 2016, time=2016-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57162, encodeId=d2205e16212, content=怎么说呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Thu Jan 14 07:16:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57102, encodeId=80ad5e1021f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Wed Jan 13 23:32:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57029, encodeId=deca5e0298e, content=度爷, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Jan 13 18:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57024, encodeId=3f6c5e02417, content=对就是对,错就是错, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/e3b78fdf1c4d3e2e9ec6e03f643df0e2/6ca494c7b27a25fdde0721c5dac778d7.jpg, createdBy=2e441664544, createdName=鲜花飞鸟, createdTime=Wed Jan 13 18:27:00 CST 2016, time=2016-01-13, status=1, ipAttribution=)]
    2016-01-14 Lynee劲飞扬

    怎么说呢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1591872, encodeId=80d915918e25e, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Fri Jan 15 09:06:00 CST 2016, time=2016-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57162, encodeId=d2205e16212, content=怎么说呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Thu Jan 14 07:16:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57102, encodeId=80ad5e1021f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Wed Jan 13 23:32:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57029, encodeId=deca5e0298e, content=度爷, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Jan 13 18:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57024, encodeId=3f6c5e02417, content=对就是对,错就是错, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/e3b78fdf1c4d3e2e9ec6e03f643df0e2/6ca494c7b27a25fdde0721c5dac778d7.jpg, createdBy=2e441664544, createdName=鲜花飞鸟, createdTime=Wed Jan 13 18:27:00 CST 2016, time=2016-01-13, status=1, ipAttribution=)]
    2016-01-13 zhuzhuba1

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1591872, encodeId=80d915918e25e, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Fri Jan 15 09:06:00 CST 2016, time=2016-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57162, encodeId=d2205e16212, content=怎么说呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Thu Jan 14 07:16:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57102, encodeId=80ad5e1021f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Wed Jan 13 23:32:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57029, encodeId=deca5e0298e, content=度爷, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Jan 13 18:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57024, encodeId=3f6c5e02417, content=对就是对,错就是错, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/e3b78fdf1c4d3e2e9ec6e03f643df0e2/6ca494c7b27a25fdde0721c5dac778d7.jpg, createdBy=2e441664544, createdName=鲜花飞鸟, createdTime=Wed Jan 13 18:27:00 CST 2016, time=2016-01-13, status=1, ipAttribution=)]
    2016-01-13 老段

    度爷

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1591872, encodeId=80d915918e25e, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Fri Jan 15 09:06:00 CST 2016, time=2016-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57162, encodeId=d2205e16212, content=怎么说呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160113/IMG569619FEB03536446.jpg, createdBy=85f81678980, createdName=Lynee劲飞扬, createdTime=Thu Jan 14 07:16:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57102, encodeId=80ad5e1021f, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Wed Jan 13 23:32:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57029, encodeId=deca5e0298e, content=度爷, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Jan 13 18:58:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57024, encodeId=3f6c5e02417, content=对就是对,错就是错, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/e3b78fdf1c4d3e2e9ec6e03f643df0e2/6ca494c7b27a25fdde0721c5dac778d7.jpg, createdBy=2e441664544, createdName=鲜花飞鸟, createdTime=Wed Jan 13 18:27:00 CST 2016, time=2016-01-13, status=1, ipAttribution=)]
    2016-01-13 鲜花飞鸟

    对就是对,错就是错

    0

相关资讯

为何金酸莓奖最差女配角会收到FDA的警告信?

近日,美国食品与药品监督管理局FDA发出了一封警告信,要求美国女星金·卡戴珊(Kim Kardashian)删除其在 Instagram(属于Facebook的一款图片分享程序)上的一条关于镇吐药的帖子。信中还要求卡戴珊同 Instagram平台澄清,药厂向FDA做书面解释。金·卡戴珊,2007年因为“性爱录影带”事件而走红,2014年因《婚姻顾问》获得金酸莓奖最差女配角。近日,其在In

医疗工作场所防止暴力行为对策汇总

由于种种原因,如今医患之间的紧张情绪似有绷紧之势,时有医患之间的恶性暴力事件发生。为了确保医疗环境健康有序、确保医生的身心健康、确保中国医改大计顺利推进,兹制定医疗工作场所防止暴力行为中国版指南,医务人员应当在恪守职业职责,尽心尽力解除患者的疾痛,努力维护医患和谐的前提下,参考使用本指南。 一、简介 本指南主要分为事前防范、事中应对和事后处理三部分。分别针对医疗场所暴力事件的萌芽、

Baidu
map
Baidu
map
Baidu
map